BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22986797)

  • 1. Co-occurring psychotic and addictive disorders: neurobiology and diagnosis.
    Ross S; Peselow E
    Clin Neuropharmacol; 2012; 35(5):235-43. PubMed ID: 22986797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use and psychosis.
    Pawsey B; Castle D
    Aust Fam Physician; 2006 Mar; 35(3):110-2. PubMed ID: 16525520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of cough mixture abusers referred to three substance abuse clinics in Hong Kong: a retrospective study.
    Tang AK; Tang WK; Liang HJ; Chan F; Mak SC; Ungvari GS
    East Asian Arch Psychiatry; 2012 Dec; 22(4):154-9. PubMed ID: 23271584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of co-occurring psychotic and substance use disorders.
    Mueser KT; Gingerich S
    Soc Work Public Health; 2013; 28(3-4):424-39. PubMed ID: 23731429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms.
    Kamali M; McTigue O; Whitty P; Gervin M; Clarke M; Browne S; Larkin C; O'Callaghan E
    Early Interv Psychiatry; 2009 Aug; 3(3):198-203. PubMed ID: 22640383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responding to the threat of HIV among persons with mental illness and substance abuse.
    Parry CD; Blank MB; Pithey AL
    Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic challenges in children and adolescents with psychotic disorders.
    Reimherr JP; McClellan JM
    J Clin Psychiatry; 2004; 65 Suppl 6():5-11. PubMed ID: 15104521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DSM-V research agenda: substance abuse/psychosis comorbidity.
    Rounsaville BJ
    Schizophr Bull; 2007 Jul; 33(4):947-52. PubMed ID: 17556751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].
    Gouzoulis-Mayfrank E
    Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):245-53. PubMed ID: 18654956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term level of functioning in patients admitted for psychotic disorders with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2006; 60(2):121-5. PubMed ID: 16635930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.